# Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD

> **NCT02470234** · PHASE4 · COMPLETED · sponsor: **Rhodes Pharmaceuticals, L.P.** · enrollment: 10 (actual)

## Conditions studied

- Attention-Deficit/Hyperactivity Disorder

## Interventions

- **DRUG:** Methylphenidate HCl ER Capsules, 10 mg
- **DRUG:** Methylphenidate HCl ER Capsules, 15 mg
- **DRUG:** Methylphenidate HCl ER Capsules, 20 mg

## Key facts

- **NCT ID:** NCT02470234
- **Lead sponsor:** Rhodes Pharmaceuticals, L.P.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-30
- **Primary completion:** 2017-07-20
- **Final completion:** 2017-08-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02470234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02470234, "Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02470234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*